# FDA Inspection 1121354 - Biomat USA, Inc - February 20, 2020

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f0cafaf9-7ada-40cf-95fc-7517483300a8
Source feed: FDA_Inspections

> FDA Inspection 1121354 for Biomat USA, Inc on February 20, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121354
- Company Name: Biomat USA, Inc
- Inspection Date: 2020-02-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 961061 - 2016-03-04](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/1c9b2838-01f1-42f4-a1f5-ca814e09aeca)

Company: https://www.keypedia.com/companies/biomat-usa-inc/d0c2fd31-4b0e-4e4c-83f1-8541cf4a884e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d